Edition:
United Kingdom

Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

10.30USD
22 Jul 2019
Change (% chg)

$0.48 (+4.89%)
Prev Close
$9.82
Open
$9.83
Day's High
$10.30
Day's Low
$9.70
Volume
264,931
Avg. Vol
297,775
52-wk High
$20.85
52-wk Low
$9.51

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Robert Azelby

51 2018 President, Chief Executive Officer, Director

Carlos Campoy

54 2018 Chief Financial Officer

Erin Lavelle

41 2018 Chief Operating Officer

James Bucher

53 2019 Executive Vice President, General Counsel

Randal Hassler

61 2018 Executive Vice President, Pharmaceutical Operations